IN SR0113

Urges the Department of Health and Human Services to include all FDA-approved prescription contraceptive drugs and devices on the list of women's preventive health care services exempt from cost-sharing under the Affordable Care Act's Section 2713.

Affirms that affordable access to preventive health care services improves health outcomes for all Americans.

Cites that half of all U.S. pregnancies are unintended, with disparities among racial groups (69% among African-American women, 54% among Latina women, 40% among Caucasian women).

Notes that birth control provides additional health benefits beyond pregnancy prevention, including reduced risk of endometrial and ovarian cancers, ectopic pregnancy, and pelvic inflammatory disease.

Highlights that cost is a major barrier to consistent contraceptive use, with 34% of women voters and 55% of younger women reporting difficulty affording birth control at some point in their lives.